nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—CYP3A4—bone cancer	0.403	1	CbGaD
Ciprofloxacin—TOP2A—Epirubicin—bone cancer	0.21	0.549	CbGbCtD
Ciprofloxacin—TOP2A—Doxorubicin—bone cancer	0.112	0.292	CbGbCtD
Ciprofloxacin—ABCB1—Cisplatin—bone cancer	0.0223	0.0583	CbGbCtD
Ciprofloxacin—ABCB1—Doxorubicin—bone cancer	0.0149	0.0391	CbGbCtD
Ciprofloxacin—ABCB1—Methotrexate—bone cancer	0.0145	0.0378	CbGbCtD
Ciprofloxacin—CYP3A4—Doxorubicin—bone cancer	0.00895	0.0234	CbGbCtD
Ciprofloxacin—TOP2A—Gastric Cancer Network 1—C21orf33—bone cancer	0.0046	0.116	CbGpPWpGaD
Ciprofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.00266	0.0671	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00203	0.0513	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00153	0.0387	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00111	0.028	CbGpPWpGaD
Ciprofloxacin—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000838	0.0212	CbGpPWpGaD
Ciprofloxacin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000785	0.0198	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000784	0.0198	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000745	0.0188	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.000738	0.0187	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.00071	0.018	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000666	0.0168	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000659	0.0166	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000629	0.0159	CbGpPWpGaD
Ciprofloxacin—TOP2A—Doxorubicin—Epirubicin—bone cancer	0.000591	0.173	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Epirubicin—bone cancer	0.000591	0.173	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Epirubicin—bone cancer	0.000591	0.173	CbGdCrCtD
Ciprofloxacin—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000556	0.0141	CbGpPWpGaD
Ciprofloxacin—TOP2A—Epirubicin—Doxorubicin—bone cancer	0.000547	0.16	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Doxorubicin—bone cancer	0.000547	0.16	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Doxorubicin—bone cancer	0.000547	0.16	CbGdCrCtD
Ciprofloxacin—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000534	0.0135	CbGpPWpGaD
Ciprofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.000516	0.013	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000514	0.013	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000513	0.013	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000484	0.0122	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000476	0.012	CbGpPWpGaD
Ciprofloxacin—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000459	0.0116	CbGpPWpGaD
Ciprofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000451	0.0114	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000445	0.0113	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000384	0.00972	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000367	0.00927	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00036	0.0091	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.00035	0.00884	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000335	0.00847	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000322	0.00813	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000313	0.00792	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000309	0.00782	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000307	0.00775	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000303	0.00765	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000287	0.00725	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000285	0.00721	CbGpPWpGaD
Ciprofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000284	0.00718	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000278	0.00702	CbGpPWpGaD
Ciprofloxacin—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000277	0.00699	CbGpPWpGaD
Ciprofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—bone cancer	0.000271	0.00684	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—ZW10—bone cancer	0.00027	0.00682	CbGpPWpGaD
Ciprofloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000263	0.00666	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000249	0.00628	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000243	0.00613	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—ZW10—bone cancer	0.000241	0.0061	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000234	0.00591	CbGpPWpGaD
Ciprofloxacin—TOP2A—Gastric Cancer Network 2—TP53—bone cancer	0.000227	0.00574	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000222	0.0056	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000221	0.00559	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000221	0.00558	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000219	0.00553	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—GNA11—bone cancer	0.000213	0.00538	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—EZH2—bone cancer	0.000212	0.00536	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00021	0.00532	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000204	0.00517	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000203	0.00514	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000201	0.00508	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000198	0.00502	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	0.000185	0.00469	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—TUBB4B—bone cancer	0.000183	0.00462	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000181	0.00458	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00018	0.00454	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000173	0.00438	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000168	0.00425	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—RFC1—bone cancer	0.000166	0.00419	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000165	0.00417	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000165	0.00416	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	0.000143	0.00362	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000134	0.00338	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000132	0.00334	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000132	0.00333	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.00013	0.00329	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000125	0.00315	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—CDK4—bone cancer	0.00012	0.00303	CbGpPWpGaD
Ciprofloxacin—Levofloxacin—CYP3A4—bone cancer	0.000115	0.552	CrCbGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	0.000115	0.00291	CbGpPWpGaD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000115	0.0029	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000113	0.00285	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000111	0.00282	CbGpPWpGaD
Ciprofloxacin—Haemoglobin—Epirubicin—bone cancer	0.00011	0.000643	CcSEcCtD
Ciprofloxacin—Stomatitis—Doxorubicin—bone cancer	0.00011	0.000643	CcSEcCtD
Ciprofloxacin—Jaundice—Doxorubicin—bone cancer	0.00011	0.000643	CcSEcCtD
Ciprofloxacin—Rhinitis—Epirubicin—bone cancer	0.00011	0.000642	CcSEcCtD
Ciprofloxacin—Conjunctivitis—Doxorubicin—bone cancer	0.00011	0.000641	CcSEcCtD
Ciprofloxacin—Haemorrhage—Epirubicin—bone cancer	0.00011	0.00064	CcSEcCtD
Ciprofloxacin—Hepatitis—Epirubicin—bone cancer	0.00011	0.00064	CcSEcCtD
Ciprofloxacin—Eye disorder—Methotrexate—bone cancer	0.00011	0.000639	CcSEcCtD
Ciprofloxacin—Tinnitus—Methotrexate—bone cancer	0.000109	0.000638	CcSEcCtD
Ciprofloxacin—Hypoaesthesia—Epirubicin—bone cancer	0.000109	0.000637	CcSEcCtD
Ciprofloxacin—Asthenia—Cisplatin—bone cancer	0.000109	0.000635	CcSEcCtD
Ciprofloxacin—Pharyngitis—Epirubicin—bone cancer	0.000109	0.000635	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Methotrexate—bone cancer	0.000109	0.000635	CcSEcCtD
Ciprofloxacin—Sweating—Doxorubicin—bone cancer	0.000109	0.000632	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Epirubicin—bone cancer	0.000108	0.000632	CcSEcCtD
Ciprofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000108	0.00274	CbGpPWpGaD
Ciprofloxacin—Oedema peripheral—Epirubicin—bone cancer	0.000108	0.000631	CcSEcCtD
Ciprofloxacin—Haematuria—Doxorubicin—bone cancer	0.000108	0.000629	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Epirubicin—bone cancer	0.000108	0.000629	CcSEcCtD
Ciprofloxacin—Urethral disorder—Epirubicin—bone cancer	0.000108	0.000627	CcSEcCtD
Ciprofloxacin—Hepatobiliary disease—Doxorubicin—bone cancer	0.000107	0.000624	CcSEcCtD
Ciprofloxacin—Epistaxis—Doxorubicin—bone cancer	0.000107	0.000622	CcSEcCtD
Ciprofloxacin—Angiopathy—Methotrexate—bone cancer	0.000106	0.000621	CcSEcCtD
Ciprofloxacin—Immune system disorder—Methotrexate—bone cancer	0.000106	0.000618	CcSEcCtD
Ciprofloxacin—Visual impairment—Epirubicin—bone cancer	0.000106	0.000617	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Methotrexate—bone cancer	0.000106	0.000616	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Doxorubicin—bone cancer	0.000106	0.000616	CcSEcCtD
Ciprofloxacin—Chills—Methotrexate—bone cancer	0.000105	0.000614	CcSEcCtD
Ciprofloxacin—Diarrhoea—Cisplatin—bone cancer	0.000104	0.000606	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Epirubicin—bone cancer	0.000104	0.000605	CcSEcCtD
Ciprofloxacin—Alopecia—Methotrexate—bone cancer	0.000104	0.000604	CcSEcCtD
Ciprofloxacin—Bradycardia—Doxorubicin—bone cancer	0.000103	0.000603	CcSEcCtD
Ciprofloxacin—Mental disorder—Methotrexate—bone cancer	0.000103	0.000599	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—DHFR—bone cancer	0.000103	0.0026	CbGpPWpGaD
Ciprofloxacin—Eye disorder—Epirubicin—bone cancer	0.000103	0.000598	CcSEcCtD
Ciprofloxacin—Tinnitus—Epirubicin—bone cancer	0.000102	0.000597	CcSEcCtD
Ciprofloxacin—Malnutrition—Methotrexate—bone cancer	0.000102	0.000595	CcSEcCtD
Ciprofloxacin—Erythema—Methotrexate—bone cancer	0.000102	0.000595	CcSEcCtD
Ciprofloxacin—Haemoglobin—Doxorubicin—bone cancer	0.000102	0.000595	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Epirubicin—bone cancer	0.000102	0.000594	CcSEcCtD
Ciprofloxacin—Flushing—Epirubicin—bone cancer	0.000102	0.000594	CcSEcCtD
Ciprofloxacin—Rhinitis—Doxorubicin—bone cancer	0.000102	0.000594	CcSEcCtD
Ciprofloxacin—Hepatitis—Doxorubicin—bone cancer	0.000102	0.000592	CcSEcCtD
Ciprofloxacin—Haemorrhage—Doxorubicin—bone cancer	0.000102	0.000592	CcSEcCtD
Ciprofloxacin—Hypoaesthesia—Doxorubicin—bone cancer	0.000101	0.000589	CcSEcCtD
Ciprofloxacin—Pharyngitis—Doxorubicin—bone cancer	0.000101	0.000588	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Doxorubicin—bone cancer	0.0001	0.000585	CcSEcCtD
Ciprofloxacin—Oedema peripheral—Doxorubicin—bone cancer	0.0001	0.000583	CcSEcCtD
Ciprofloxacin—Dysgeusia—Methotrexate—bone cancer	0.0001	0.000583	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Doxorubicin—bone cancer	9.99e-05	0.000582	CcSEcCtD
Ciprofloxacin—Angiopathy—Epirubicin—bone cancer	9.97e-05	0.000581	CcSEcCtD
Ciprofloxacin—Urethral disorder—Doxorubicin—bone cancer	9.96e-05	0.000581	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	9.95e-05	0.00252	CbGpPWpGaD
Ciprofloxacin—Immune system disorder—Epirubicin—bone cancer	9.92e-05	0.000578	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Epirubicin—bone cancer	9.9e-05	0.000577	CcSEcCtD
Ciprofloxacin—Back pain—Methotrexate—bone cancer	9.88e-05	0.000576	CcSEcCtD
Ciprofloxacin—Chills—Epirubicin—bone cancer	9.86e-05	0.000574	CcSEcCtD
Ciprofloxacin—Arrhythmia—Epirubicin—bone cancer	9.81e-05	0.000572	CcSEcCtD
Ciprofloxacin—Visual impairment—Doxorubicin—bone cancer	9.79e-05	0.000571	CcSEcCtD
Ciprofloxacin—Alopecia—Epirubicin—bone cancer	9.71e-05	0.000566	CcSEcCtD
Ciprofloxacin—Vomiting—Cisplatin—bone cancer	9.66e-05	0.000563	CcSEcCtD
Ciprofloxacin—Vision blurred—Methotrexate—bone cancer	9.63e-05	0.000561	CcSEcCtD
Ciprofloxacin—Mental disorder—Epirubicin—bone cancer	9.62e-05	0.000561	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Doxorubicin—bone cancer	9.61e-05	0.00056	CcSEcCtD
Ciprofloxacin—Rash—Cisplatin—bone cancer	9.58e-05	0.000558	CcSEcCtD
Ciprofloxacin—Dermatitis—Cisplatin—bone cancer	9.57e-05	0.000558	CcSEcCtD
Ciprofloxacin—Erythema—Epirubicin—bone cancer	9.56e-05	0.000557	CcSEcCtD
Ciprofloxacin—Malnutrition—Epirubicin—bone cancer	9.56e-05	0.000557	CcSEcCtD
Ciprofloxacin—CYP3A5—Biological oxidations—CYP3A4—bone cancer	9.55e-05	0.00241	CbGpPWpGaD
Ciprofloxacin—Eye disorder—Doxorubicin—bone cancer	9.5e-05	0.000553	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Methotrexate—bone cancer	9.48e-05	0.000552	CcSEcCtD
Ciprofloxacin—Tinnitus—Doxorubicin—bone cancer	9.48e-05	0.000552	CcSEcCtD
Ciprofloxacin—Anaemia—Methotrexate—bone cancer	9.44e-05	0.00055	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Doxorubicin—bone cancer	9.43e-05	0.00055	CcSEcCtD
Ciprofloxacin—Flushing—Doxorubicin—bone cancer	9.43e-05	0.00055	CcSEcCtD
Ciprofloxacin—Flatulence—Epirubicin—bone cancer	9.42e-05	0.000549	CcSEcCtD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	9.41e-05	0.00238	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	9.39e-05	0.00237	CbGpPWpGaD
Ciprofloxacin—Tension—Epirubicin—bone cancer	9.38e-05	0.000547	CcSEcCtD
Ciprofloxacin—Dysgeusia—Epirubicin—bone cancer	9.36e-05	0.000546	CcSEcCtD
Ciprofloxacin—Norfloxacin—CYP3A4—bone cancer	9.36e-05	0.448	CrCbGaD
Ciprofloxacin—Nervousness—Epirubicin—bone cancer	9.29e-05	0.000541	CcSEcCtD
Ciprofloxacin—Back pain—Epirubicin—bone cancer	9.25e-05	0.000539	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	9.25e-05	0.00234	CbGpPWpGaD
Ciprofloxacin—Angiopathy—Doxorubicin—bone cancer	9.22e-05	0.000537	CcSEcCtD
Ciprofloxacin—Malaise—Methotrexate—bone cancer	9.21e-05	0.000537	CcSEcCtD
Ciprofloxacin—Muscle spasms—Epirubicin—bone cancer	9.19e-05	0.000536	CcSEcCtD
Ciprofloxacin—Immune system disorder—Doxorubicin—bone cancer	9.18e-05	0.000535	CcSEcCtD
Ciprofloxacin—Vertigo—Methotrexate—bone cancer	9.18e-05	0.000535	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Doxorubicin—bone cancer	9.16e-05	0.000534	CcSEcCtD
Ciprofloxacin—Leukopenia—Methotrexate—bone cancer	9.15e-05	0.000533	CcSEcCtD
Ciprofloxacin—Chills—Doxorubicin—bone cancer	9.12e-05	0.000531	CcSEcCtD
Ciprofloxacin—Arrhythmia—Doxorubicin—bone cancer	9.08e-05	0.000529	CcSEcCtD
Ciprofloxacin—Nausea—Cisplatin—bone cancer	9.03e-05	0.000526	CcSEcCtD
Ciprofloxacin—Vision blurred—Epirubicin—bone cancer	9.01e-05	0.000525	CcSEcCtD
Ciprofloxacin—Alopecia—Doxorubicin—bone cancer	8.98e-05	0.000523	CcSEcCtD
Ciprofloxacin—Cough—Methotrexate—bone cancer	8.92e-05	0.00052	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	8.91e-05	0.00225	CbGpPWpGaD
Ciprofloxacin—Mental disorder—Doxorubicin—bone cancer	8.9e-05	0.000519	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	8.9e-05	0.00225	CbGpPWpGaD
Ciprofloxacin—Ill-defined disorder—Epirubicin—bone cancer	8.87e-05	0.000517	CcSEcCtD
Ciprofloxacin—Convulsion—Methotrexate—bone cancer	8.85e-05	0.000516	CcSEcCtD
Ciprofloxacin—Erythema—Doxorubicin—bone cancer	8.85e-05	0.000516	CcSEcCtD
Ciprofloxacin—Malnutrition—Doxorubicin—bone cancer	8.85e-05	0.000516	CcSEcCtD
Ciprofloxacin—Anaemia—Epirubicin—bone cancer	8.84e-05	0.000515	CcSEcCtD
Ciprofloxacin—Agitation—Epirubicin—bone cancer	8.79e-05	0.000512	CcSEcCtD
Ciprofloxacin—Flatulence—Doxorubicin—bone cancer	8.72e-05	0.000508	CcSEcCtD
Ciprofloxacin—Myalgia—Methotrexate—bone cancer	8.7e-05	0.000507	CcSEcCtD
Ciprofloxacin—Chest pain—Methotrexate—bone cancer	8.7e-05	0.000507	CcSEcCtD
Ciprofloxacin—Arthralgia—Methotrexate—bone cancer	8.7e-05	0.000507	CcSEcCtD
Ciprofloxacin—Tension—Doxorubicin—bone cancer	8.68e-05	0.000506	CcSEcCtD
Ciprofloxacin—Dysgeusia—Doxorubicin—bone cancer	8.66e-05	0.000505	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	8.64e-05	0.000503	CcSEcCtD
Ciprofloxacin—Malaise—Epirubicin—bone cancer	8.62e-05	0.000502	CcSEcCtD
Ciprofloxacin—Discomfort—Methotrexate—bone cancer	8.59e-05	0.000501	CcSEcCtD
Ciprofloxacin—Nervousness—Doxorubicin—bone cancer	8.59e-05	0.000501	CcSEcCtD
Ciprofloxacin—Vertigo—Epirubicin—bone cancer	8.59e-05	0.000501	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—CHEK2—bone cancer	8.59e-05	0.00217	CbGpPWpGaD
Ciprofloxacin—Syncope—Epirubicin—bone cancer	8.57e-05	0.0005	CcSEcCtD
Ciprofloxacin—Leukopenia—Epirubicin—bone cancer	8.56e-05	0.000499	CcSEcCtD
Ciprofloxacin—Back pain—Doxorubicin—bone cancer	8.56e-05	0.000499	CcSEcCtD
Ciprofloxacin—Muscle spasms—Doxorubicin—bone cancer	8.51e-05	0.000496	CcSEcCtD
Ciprofloxacin—Palpitations—Epirubicin—bone cancer	8.45e-05	0.000492	CcSEcCtD
Ciprofloxacin—Confusional state—Methotrexate—bone cancer	8.41e-05	0.00049	CcSEcCtD
Ciprofloxacin—CYP1A2—Phase II conjugation—GSTP1—bone cancer	8.41e-05	0.00213	CbGpPWpGaD
Ciprofloxacin—Loss of consciousness—Epirubicin—bone cancer	8.4e-05	0.00049	CcSEcCtD
Ciprofloxacin—Cough—Epirubicin—bone cancer	8.34e-05	0.000486	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Methotrexate—bone cancer	8.34e-05	0.000486	CcSEcCtD
Ciprofloxacin—Vision blurred—Doxorubicin—bone cancer	8.34e-05	0.000486	CcSEcCtD
Ciprofloxacin—Convulsion—Epirubicin—bone cancer	8.28e-05	0.000483	CcSEcCtD
Ciprofloxacin—Hypertension—Epirubicin—bone cancer	8.25e-05	0.000481	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Doxorubicin—bone cancer	8.21e-05	0.000478	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Methotrexate—bone cancer	8.18e-05	0.000477	CcSEcCtD
Ciprofloxacin—Anaemia—Doxorubicin—bone cancer	8.18e-05	0.000477	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Methotrexate—bone cancer	8.16e-05	0.000476	CcSEcCtD
Ciprofloxacin—CYP3A5—Biological oxidations—GSTP1—bone cancer	8.16e-05	0.00206	CbGpPWpGaD
Ciprofloxacin—Chest pain—Epirubicin—bone cancer	8.14e-05	0.000474	CcSEcCtD
Ciprofloxacin—Arthralgia—Epirubicin—bone cancer	8.14e-05	0.000474	CcSEcCtD
Ciprofloxacin—Myalgia—Epirubicin—bone cancer	8.14e-05	0.000474	CcSEcCtD
Ciprofloxacin—Agitation—Doxorubicin—bone cancer	8.13e-05	0.000474	CcSEcCtD
Ciprofloxacin—Anxiety—Epirubicin—bone cancer	8.11e-05	0.000473	CcSEcCtD
Ciprofloxacin—Skin disorder—Methotrexate—bone cancer	8.1e-05	0.000472	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	8.08e-05	0.000471	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Methotrexate—bone cancer	8.06e-05	0.00047	CcSEcCtD
Ciprofloxacin—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	8.05e-05	0.00204	CbGpPWpGaD
Ciprofloxacin—Discomfort—Epirubicin—bone cancer	8.04e-05	0.000469	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	8.04e-05	0.00203	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	7.99e-05	0.00202	CbGpPWpGaD
Ciprofloxacin—Malaise—Doxorubicin—bone cancer	7.98e-05	0.000465	CcSEcCtD
Ciprofloxacin—Dry mouth—Epirubicin—bone cancer	7.96e-05	0.000464	CcSEcCtD
Ciprofloxacin—Vertigo—Doxorubicin—bone cancer	7.95e-05	0.000463	CcSEcCtD
Ciprofloxacin—Anorexia—Methotrexate—bone cancer	7.95e-05	0.000463	CcSEcCtD
Ciprofloxacin—Syncope—Doxorubicin—bone cancer	7.93e-05	0.000462	CcSEcCtD
Ciprofloxacin—Leukopenia—Doxorubicin—bone cancer	7.92e-05	0.000461	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—NDUFA12—bone cancer	7.92e-05	0.002	CbGpPWpGaD
Ciprofloxacin—Confusional state—Epirubicin—bone cancer	7.87e-05	0.000459	CcSEcCtD
Ciprofloxacin—Palpitations—Doxorubicin—bone cancer	7.82e-05	0.000456	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Epirubicin—bone cancer	7.8e-05	0.000455	CcSEcCtD
Ciprofloxacin—Oedema—Epirubicin—bone cancer	7.8e-05	0.000455	CcSEcCtD
Ciprofloxacin—Hypotension—Methotrexate—bone cancer	7.79e-05	0.000454	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Doxorubicin—bone cancer	7.78e-05	0.000453	CcSEcCtD
Ciprofloxacin—Cough—Doxorubicin—bone cancer	7.72e-05	0.00045	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—JUN—bone cancer	7.71e-05	0.00195	CbGpPWpGaD
Ciprofloxacin—Shock—Epirubicin—bone cancer	7.68e-05	0.000447	CcSEcCtD
Ciprofloxacin—Convulsion—Doxorubicin—bone cancer	7.67e-05	0.000447	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Epirubicin—bone cancer	7.65e-05	0.000446	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Epirubicin—bone cancer	7.64e-05	0.000445	CcSEcCtD
Ciprofloxacin—Hypertension—Doxorubicin—bone cancer	7.64e-05	0.000445	CcSEcCtD
Ciprofloxacin—Tachycardia—Epirubicin—bone cancer	7.62e-05	0.000444	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Methotrexate—bone cancer	7.6e-05	0.000443	CcSEcCtD
Ciprofloxacin—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	7.59e-05	0.00192	CbGpPWpGaD
Ciprofloxacin—Skin disorder—Epirubicin—bone cancer	7.58e-05	0.000442	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Epirubicin—bone cancer	7.54e-05	0.00044	CcSEcCtD
Ciprofloxacin—Insomnia—Methotrexate—bone cancer	7.54e-05	0.00044	CcSEcCtD
Ciprofloxacin—Arthralgia—Doxorubicin—bone cancer	7.53e-05	0.000439	CcSEcCtD
Ciprofloxacin—Myalgia—Doxorubicin—bone cancer	7.53e-05	0.000439	CcSEcCtD
Ciprofloxacin—Chest pain—Doxorubicin—bone cancer	7.53e-05	0.000439	CcSEcCtD
Ciprofloxacin—Anxiety—Doxorubicin—bone cancer	7.51e-05	0.000437	CcSEcCtD
Ciprofloxacin—Paraesthesia—Methotrexate—bone cancer	7.49e-05	0.000436	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	7.48e-05	0.000436	CcSEcCtD
Ciprofloxacin—Discomfort—Doxorubicin—bone cancer	7.44e-05	0.000434	CcSEcCtD
Ciprofloxacin—Anorexia—Epirubicin—bone cancer	7.44e-05	0.000433	CcSEcCtD
Ciprofloxacin—Dyspnoea—Methotrexate—bone cancer	7.43e-05	0.000433	CcSEcCtD
Ciprofloxacin—Somnolence—Methotrexate—bone cancer	7.41e-05	0.000432	CcSEcCtD
Ciprofloxacin—Dry mouth—Doxorubicin—bone cancer	7.37e-05	0.000429	CcSEcCtD
Ciprofloxacin—Dyspepsia—Methotrexate—bone cancer	7.34e-05	0.000428	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	7.32e-05	0.00185	CbGpPWpGaD
Ciprofloxacin—Hypotension—Epirubicin—bone cancer	7.29e-05	0.000425	CcSEcCtD
Ciprofloxacin—Confusional state—Doxorubicin—bone cancer	7.28e-05	0.000424	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—BRCA2—bone cancer	7.28e-05	0.00184	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	7.27e-05	0.00184	CbGpPWpGaD
Ciprofloxacin—Decreased appetite—Methotrexate—bone cancer	7.25e-05	0.000422	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Doxorubicin—bone cancer	7.22e-05	0.000421	CcSEcCtD
Ciprofloxacin—Oedema—Doxorubicin—bone cancer	7.22e-05	0.000421	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Methotrexate—bone cancer	7.2e-05	0.00042	CcSEcCtD
Ciprofloxacin—Fatigue—Methotrexate—bone cancer	7.19e-05	0.000419	CcSEcCtD
Ciprofloxacin—Pain—Methotrexate—bone cancer	7.13e-05	0.000416	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Epirubicin—bone cancer	7.11e-05	0.000414	CcSEcCtD
Ciprofloxacin—Shock—Doxorubicin—bone cancer	7.1e-05	0.000414	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Doxorubicin—bone cancer	7.08e-05	0.000413	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Doxorubicin—bone cancer	7.07e-05	0.000412	CcSEcCtD
Ciprofloxacin—Insomnia—Epirubicin—bone cancer	7.06e-05	0.000411	CcSEcCtD
Ciprofloxacin—Tachycardia—Doxorubicin—bone cancer	7.05e-05	0.000411	CcSEcCtD
Ciprofloxacin—Skin disorder—Doxorubicin—bone cancer	7.01e-05	0.000409	CcSEcCtD
Ciprofloxacin—Paraesthesia—Epirubicin—bone cancer	7.01e-05	0.000408	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Doxorubicin—bone cancer	6.98e-05	0.000407	CcSEcCtD
Ciprofloxacin—Dyspnoea—Epirubicin—bone cancer	6.96e-05	0.000405	CcSEcCtD
Ciprofloxacin—Somnolence—Epirubicin—bone cancer	6.94e-05	0.000404	CcSEcCtD
Ciprofloxacin—Anorexia—Doxorubicin—bone cancer	6.88e-05	0.000401	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Methotrexate—bone cancer	6.87e-05	0.0004	CcSEcCtD
Ciprofloxacin—Dyspepsia—Epirubicin—bone cancer	6.87e-05	0.0004	CcSEcCtD
Ciprofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	6.85e-05	0.00173	CbGpPWpGaD
Ciprofloxacin—Gastrointestinal pain—Methotrexate—bone cancer	6.82e-05	0.000397	CcSEcCtD
Ciprofloxacin—Decreased appetite—Epirubicin—bone cancer	6.78e-05	0.000395	CcSEcCtD
Ciprofloxacin—Hypotension—Doxorubicin—bone cancer	6.75e-05	0.000393	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Epirubicin—bone cancer	6.74e-05	0.000393	CcSEcCtD
Ciprofloxacin—Fatigue—Epirubicin—bone cancer	6.73e-05	0.000392	CcSEcCtD
Ciprofloxacin—Pain—Epirubicin—bone cancer	6.67e-05	0.000389	CcSEcCtD
Ciprofloxacin—Constipation—Epirubicin—bone cancer	6.67e-05	0.000389	CcSEcCtD
Ciprofloxacin—Urticaria—Methotrexate—bone cancer	6.62e-05	0.000386	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.62e-05	0.00167	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	6.6e-05	0.00167	CbGpPWpGaD
Ciprofloxacin—Abdominal pain—Methotrexate—bone cancer	6.59e-05	0.000384	CcSEcCtD
Ciprofloxacin—Body temperature increased—Methotrexate—bone cancer	6.59e-05	0.000384	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Doxorubicin—bone cancer	6.58e-05	0.000383	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—NT5C3A—bone cancer	6.56e-05	0.00166	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.53e-05	0.00165	CbGpPWpGaD
Ciprofloxacin—Insomnia—Doxorubicin—bone cancer	6.53e-05	0.000381	CcSEcCtD
Ciprofloxacin—Paraesthesia—Doxorubicin—bone cancer	6.48e-05	0.000378	CcSEcCtD
Ciprofloxacin—Dyspnoea—Doxorubicin—bone cancer	6.44e-05	0.000375	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Epirubicin—bone cancer	6.43e-05	0.000375	CcSEcCtD
Ciprofloxacin—Somnolence—Doxorubicin—bone cancer	6.42e-05	0.000374	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Epirubicin—bone cancer	6.38e-05	0.000372	CcSEcCtD
Ciprofloxacin—Dyspepsia—Doxorubicin—bone cancer	6.36e-05	0.00037	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	6.32e-05	0.0016	CbGpPWpGaD
Ciprofloxacin—Decreased appetite—Doxorubicin—bone cancer	6.28e-05	0.000366	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Doxorubicin—bone cancer	6.23e-05	0.000363	CcSEcCtD
Ciprofloxacin—Fatigue—Doxorubicin—bone cancer	6.22e-05	0.000363	CcSEcCtD
Ciprofloxacin—Urticaria—Epirubicin—bone cancer	6.2e-05	0.000361	CcSEcCtD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	6.19e-05	0.00157	CbGpPWpGaD
Ciprofloxacin—Pain—Doxorubicin—bone cancer	6.17e-05	0.00036	CcSEcCtD
Ciprofloxacin—Constipation—Doxorubicin—bone cancer	6.17e-05	0.00036	CcSEcCtD
Ciprofloxacin—Abdominal pain—Epirubicin—bone cancer	6.17e-05	0.000359	CcSEcCtD
Ciprofloxacin—Body temperature increased—Epirubicin—bone cancer	6.17e-05	0.000359	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Methotrexate—bone cancer	6.14e-05	0.000358	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	6.04e-05	0.00153	CbGpPWpGaD
Ciprofloxacin—Asthenia—Methotrexate—bone cancer	5.98e-05	0.000349	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Doxorubicin—bone cancer	5.95e-05	0.000347	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Doxorubicin—bone cancer	5.9e-05	0.000344	CcSEcCtD
Ciprofloxacin—Pruritus—Methotrexate—bone cancer	5.9e-05	0.000344	CcSEcCtD
Ciprofloxacin—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.86e-05	0.00148	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Biological oxidations—CYP3A4—bone cancer	5.75e-05	0.00145	CbGpPWpGaD
Ciprofloxacin—Hypersensitivity—Epirubicin—bone cancer	5.75e-05	0.000335	CcSEcCtD
Ciprofloxacin—Urticaria—Doxorubicin—bone cancer	5.74e-05	0.000334	CcSEcCtD
Ciprofloxacin—CYP3A5—Metabolism—NDUFA12—bone cancer	5.72e-05	0.00145	CbGpPWpGaD
Ciprofloxacin—Abdominal pain—Doxorubicin—bone cancer	5.71e-05	0.000333	CcSEcCtD
Ciprofloxacin—Body temperature increased—Doxorubicin—bone cancer	5.71e-05	0.000333	CcSEcCtD
Ciprofloxacin—Diarrhoea—Methotrexate—bone cancer	5.71e-05	0.000332	CcSEcCtD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	5.67e-05	0.00143	CbGpPWpGaD
Ciprofloxacin—Asthenia—Epirubicin—bone cancer	5.6e-05	0.000326	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.54e-05	0.0014	CbGpPWpGaD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.52e-05	0.0014	CbGpPWpGaD
Ciprofloxacin—Pruritus—Epirubicin—bone cancer	5.52e-05	0.000322	CcSEcCtD
Ciprofloxacin—Dizziness—Methotrexate—bone cancer	5.51e-05	0.000321	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—CDK4—bone cancer	5.4e-05	0.00136	CbGpPWpGaD
Ciprofloxacin—Diarrhoea—Epirubicin—bone cancer	5.34e-05	0.000311	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Doxorubicin—bone cancer	5.32e-05	0.00031	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	5.3e-05	0.00134	CbGpPWpGaD
Ciprofloxacin—Vomiting—Methotrexate—bone cancer	5.3e-05	0.000309	CcSEcCtD
Ciprofloxacin—Rash—Methotrexate—bone cancer	5.26e-05	0.000306	CcSEcCtD
Ciprofloxacin—Dermatitis—Methotrexate—bone cancer	5.25e-05	0.000306	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	5.25e-05	0.00133	CbGpPWpGaD
Ciprofloxacin—Headache—Methotrexate—bone cancer	5.22e-05	0.000304	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.19e-05	0.00131	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.19e-05	0.00131	CbGpPWpGaD
Ciprofloxacin—Asthenia—Doxorubicin—bone cancer	5.18e-05	0.000302	CcSEcCtD
Ciprofloxacin—Dizziness—Epirubicin—bone cancer	5.16e-05	0.000301	CcSEcCtD
Ciprofloxacin—Pruritus—Doxorubicin—bone cancer	5.11e-05	0.000298	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—TP53—bone cancer	5.09e-05	0.00129	CbGpPWpGaD
Ciprofloxacin—Vomiting—Epirubicin—bone cancer	4.96e-05	0.000289	CcSEcCtD
Ciprofloxacin—Nausea—Methotrexate—bone cancer	4.95e-05	0.000289	CcSEcCtD
Ciprofloxacin—Diarrhoea—Doxorubicin—bone cancer	4.94e-05	0.000288	CcSEcCtD
Ciprofloxacin—Rash—Epirubicin—bone cancer	4.92e-05	0.000287	CcSEcCtD
Ciprofloxacin—CYP1A2—Biological oxidations—GSTP1—bone cancer	4.92e-05	0.00124	CbGpPWpGaD
Ciprofloxacin—Dermatitis—Epirubicin—bone cancer	4.92e-05	0.000286	CcSEcCtD
Ciprofloxacin—Headache—Epirubicin—bone cancer	4.89e-05	0.000285	CcSEcCtD
Ciprofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.85e-05	0.00123	CbGpPWpGaD
Ciprofloxacin—Dizziness—Doxorubicin—bone cancer	4.77e-05	0.000278	CcSEcCtD
Ciprofloxacin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.77e-05	0.00121	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—NT5C3A—bone cancer	4.74e-05	0.0012	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—RB1—bone cancer	4.69e-05	0.00119	CbGpPWpGaD
Ciprofloxacin—Nausea—Epirubicin—bone cancer	4.64e-05	0.00027	CcSEcCtD
Ciprofloxacin—Vomiting—Doxorubicin—bone cancer	4.59e-05	0.000268	CcSEcCtD
Ciprofloxacin—Rash—Doxorubicin—bone cancer	4.55e-05	0.000265	CcSEcCtD
Ciprofloxacin—Dermatitis—Doxorubicin—bone cancer	4.55e-05	0.000265	CcSEcCtD
Ciprofloxacin—Headache—Doxorubicin—bone cancer	4.52e-05	0.000264	CcSEcCtD
Ciprofloxacin—ABCB1—Metabolism—NDUFA12—bone cancer	4.32e-05	0.00109	CbGpPWpGaD
Ciprofloxacin—Nausea—Doxorubicin—bone cancer	4.29e-05	0.00025	CcSEcCtD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.11e-05	0.00104	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MDM2—bone cancer	4e-05	0.00101	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.8e-05	0.000959	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.74e-05	0.000946	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—NT5C3A—bone cancer	3.58e-05	0.000904	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—NDUFA12—bone cancer	3.45e-05	0.000871	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.04e-05	0.00077	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.93e-05	0.000742	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—ENO2—bone cancer	2.87e-05	0.000726	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—NT5C3A—bone cancer	2.86e-05	0.000722	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—DHFR—bone cancer	2.67e-05	0.000674	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—NDUFA12—bone cancer	2.66e-05	0.000672	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.65e-05	0.000669	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GNA11—bone cancer	2.49e-05	0.00063	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—TP53—bone cancer	2.3e-05	0.00058	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—CYP3A4—bone cancer	2.26e-05	0.000571	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—NT5C3A—bone cancer	2.2e-05	0.000557	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.08e-05	0.000526	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—ENO2—bone cancer	2.08e-05	0.000525	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GSTP1—bone cancer	1.93e-05	0.000488	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—DHFR—bone cancer	1.93e-05	0.000487	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GNA11—bone cancer	1.8e-05	0.000455	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.75e-05	0.000442	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—CYP3A4—bone cancer	1.63e-05	0.000413	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—ENO2—bone cancer	1.57e-05	0.000396	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—DHFR—bone cancer	1.45e-05	0.000367	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GSTP1—bone cancer	1.4e-05	0.000353	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GNA11—bone cancer	1.36e-05	0.000343	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—ENO2—bone cancer	1.25e-05	0.000316	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—CYP3A4—bone cancer	1.23e-05	0.000311	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—DHFR—bone cancer	1.16e-05	0.000293	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GNA11—bone cancer	1.08e-05	0.000274	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GSTP1—bone cancer	1.05e-05	0.000266	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—PTGS2—bone cancer	1e-05	0.000253	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—CYP3A4—bone cancer	9.83e-06	0.000249	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.78e-06	0.000247	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—ENO2—bone cancer	9.65e-06	0.000244	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—DHFR—bone cancer	8.96e-06	0.000226	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GSTP1—bone cancer	8.41e-06	0.000213	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GNA11—bone cancer	8.37e-06	0.000212	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PTGS2—bone cancer	7.23e-06	0.000183	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GSTP1—bone cancer	6.49e-06	0.000164	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PTGS2—bone cancer	5.46e-06	0.000138	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PTGS2—bone cancer	4.36e-06	0.00011	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PTGS2—bone cancer	3.36e-06	8.5e-05	CbGpPWpGaD
